Karsanbhai Surendralal Lanca

EMR CEO Karsanbhai Surendralal Lanca sold 5,700 shares at $142.32 on 2026-03-10; stock down 18.2% in 30 days.

Karsanbhai Surendralal Lanca, President & CEO, sold 5,700 shares (5.7K shares) at $142.32, reducing holdings from 287,093 to 281,393 shares. The transaction occurred at a price $18.64 above the current price of $132.18 and near the 52-week high of $161.69. Among his prior trades at EMR, his most recent sale on 2025-12-03 showed only a 2.1% gain over 30 days, and a 2024-11-13 sale preceded a 2.8% decline over 90 days. His cross-ticker track record shows 3 prior sells with a 33.33% well-timed rate (lower than desired), though his single buy executed with strong post-transaction gains (90d return +19.9%). The current 18.2% post-transaction decline and -18.2% 30-day change raise the question of whether this sale at $142.32 will prove prescient, but prior EMR timing results are mixed.

EMR CEO Lanca sold 7,263 shares at $133.00 for $965,979.00; retains 278,395 shares post-transaction.

Karsanbhai Surendralal Lanca, President & CEO of Emerson Electric, sold 7,263 shares at $133.00 on 2025-12-03, reducing his holdings by 2.5% while maintaining a substantial position of 278,395 shares. The current share price of $136.64 is 2.7% above the transaction price, and the stock has delivered +3.1% over the past 90 days and +8.4% over 52 weeks. In his prior trades at EMR, Lanca's sales timing has been mixed: a May 2025 sale was followed by +18.2% returns at 90 days (poorly timed), while a November 2024 sale preceded a -2.8% decline (well-timed), yielding a 50% well-timed rate at this ticker. The scale of the current sale—$966.0K—is modest relative to the company's $76.8B market cap and the CEO's total stake, and the transaction occurs at a price below the 52-week high by 8.7%, suggesting no urgency or apparent market-timing motive.

CEO Karsanbhai Lanca sold 16,698 shares of EMR at $113.33; stock is -16.2% from 52-week high but his prior EMR trades were both well-timed.

Karsanbhai Surendralal Lanca, President & CEO of Emerson Electric, sold 16,698 shares (16.7K shares) on 2025-05-08 at $113.33, reducing his holdings from 181,655 shares to 164,957 shares and realizing $1,892,384.34. The transaction occurs when EMR is trading -16.2% from its 52-week high of $134.33, creating a backdrop where sales might appear defensive. However, his same-ticker history shows 2 prior trades at EMR with a 2 of 2 well-timed pattern at the 90-day mark—a prior sell on 2024-11-13 (90d return -2.8%) and a prior buy on 2023-11-17 (90d return +19.9%)—demonstrating accuracy in his historical EMR timing. His cross-ticker track record across all open-market activity shows 1 prior sell with a 90d well-timed rate of 100.00%, consistent with the pattern at EMR. Stock fundamentals remain solid: $4.4B quarterly revenue with +15.3% annual growth and $485.0M net income, though the P/E of 26.42 suggests valuation is not depressed. The sale occurs in a near-term context (stock +7.8% over 30 days), but the 90-day perspective (stock -9.5%) aligns with his prior sell discipline.

CEO Karsanbhai Surendralal Lanca sold 52,409 shares of EMR at $130.51; holdings fall 35.2% to 96,675 shares.

CEO Karsanbhai Surendralal Lanca sold 52,409 shares (52.4K shares) at $130.51 on 2024-11-13, reducing his holdings by 35.2% from 149,084 to 96,675 shares and raising $6,839,767.57 ($6.8M). The sale occurred at $130.51, which was 2.9% above the current price of $126.78, and near the 52-week high of $130.16. His prior transaction at EMR—a buy on 2023-11-17—showed a 90-day return of +19.9%, qualifying as well-timed under the metric that positive 90-day returns after buys indicate foresight. This sale represents a substantial reduction in his direct stake in the company he leads, taking place in an environment where EMR stock has appreciated 23.0% over the prior 90 days and 14.6% over the prior 30 days.